Intervention

Gantenerumab

ClinicalTrials.gov intervention label

Clinical trials12
Recruiting0
Common conditions5
Lead sponsors shown3

Clinical trials

12 shown
A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)NCT05256134 · 2022-04-19
TERMINATED
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)NCT04374253 · 2021-01-26
TERMINATED
A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)NCT04592341 · 2020-11-18
TERMINATED
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic MutationNCT06424236 · 2020-06-03
TERMINATED
A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)NCT04339413 · 2020-05-22
TERMINATED
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)NCT03443973 · 2018-08-22
TERMINATED
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)NCT03444870 · 2018-06-06
TERMINATED
A Study of Gantenerumab in Participants With Mild Alzheimer DiseaseNCT02051608 · 2014-03-27
COMPLETED
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001NCT01760005 · 2012-12-01
ACTIVE_NOT_RECRUITING
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.NCT04623242 · 2012-12-01
COMPLETED
A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease PatientsNCT01656525 · 2012-06-01
COMPLETED
A Study of Gantenerumab in Participants With Prodromal Alzheimer's DiseaseNCT01224106 · 2010-11-30
COMPLETED

Trial status mix

TERMINATED7
COMPLETED4
ACTIVE_NOT_RECRUITING1

Phase mix

PHASE310
PHASE24
PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.